Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-11

FDA Approved: GLATIRAMER ACETATE — Original Application (AJENAT PHARMACEUTICALS LLC)

View source ↗

Summary

The FDA approved an original application for a generic glatiramer acetate product by AJENAT Pharmaceuticals LLC, enabling a generic treatment option for relapsi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

ORIG AP for GLATIRAMER ACETATE (GLATIRAMER ACETATE)